ClinicalTrials.gg
Drug

Tegoprazan clinical trials

Also written BLI5100 and CJ-12420.

studies test it
62
open now
14
in phase 3
19
first study started
2011

How each study uses tegoprazan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the tegoprazan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tegoprazan
19
K-CAB
11
Tegoprazan 50 mg
7
Tegoprazan 50mg
3
Not yet decided
3

Development codes

BLI5100
3
CJ-12420
3
LXI-15028
1

Studies by the year they started

62 studies that test it; most in 2020 (8)

Studies that test tegoprazan, by start year
YearStudies
20111
20133
20155
20163
20172
20185
20196
20208
20214
20226
20238
20244
20253
20264

By phase

A phase 1/2 study counts in both.

Phase 1
26
Phase 2
4
Phase 3
19
Phase 4
11
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 48 · Other 14

HK inno.N Corporation (37) · Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. (7) · Braintree Laboratories (3) · Xijing Hospital of Digestive Diseases (1) · Zhang Xiaofeng,MD (1) · Pusan National University Hospital (1) · Seoul National University Hospital (1) · Seok Kyeong Oh (1)

Often tested with

Tested in the same studies.

Clarithromycin (3) · Bismuth (2) · Esomeprazole (2) · Vonoprazan (2) · Minocycline (1) · Amoxicillin (1) · Edoxaban (1) · Apixaban (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3, 1 in phase 3

Studies that test tegoprazan, phase 3 first.

Studies

Open first, then newest update. How each study uses tegoprazan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 62

See all 62 studies that test tegoprazan →

Given beside what is tested · 3 — tegoprazan is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with tegoprazan

Codes

What other systems call tegoprazan · ClinicalTrials.gg INT001098

  • MeSH (NLM) C000631239tegoprazanOne source NLM
  • UNII (FDA) W017G7IF4STEGOPRAZANConfirmed FDA, NLM, Wikidata
  • Wikidata Q27292116tegoprazanConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152542TegoprazanOne source FDA
  • DrugBank DB16690One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.